Literature DB >> 7937841

Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.

D Lin1, M Fiscella, P M O'Connor, J Jackman, M Chen, L L Luo, A Sala, S Travali, E Appella, W E Mercer.   

Abstract

Overexpression of wild-type p53 protein has been shown to induce arrest in the G1 stage of the cell cycle and to transactivate expression of the gene that encodes the 21-kDa Waf1/Cip1 protein, a potent inhibitor of cyclin-dependent kinase activity. p53-dependent G1 arrest is accompanied by decreased expression of the B-myb gene, a relative of the c-myb cellular oncogene. In this study we show that B-myb expression is required for cells to progress from G1 into S phase and that high levels of ectopic B-myb expression uncoupled from cell cycle regulation rescues cells from p53-induced G1 arrest even in the presence of Waf1/Cip1 transactivation and inhibition of cyclin E/Cdk2 kinase activity. Cotransfection experiments with p53 expression plasmids and expression plasmids encoding in-frame deletion mutations in B-myb coding sequences indicate that the DNA-binding domain of the B-Myb protein is required for this activity. These results provide evidence of a bypass of p53-induced Waf1/Cip1-mediated cell cycle regulatory pathways by a member of the myb oncogene family.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937841      PMCID: PMC44961          DOI: 10.1073/pnas.91.21.10079

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.

Authors:  D Lin; M T Shields; S J Ullrich; E Appella; W E Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

Review 2.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells.

Authors:  L Hartwell
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

3.  Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression.

Authors:  A Sala; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 4.  The p53 tumor suppressor protein, a modulator of cell proliferation.

Authors:  S J Ullrich; C W Anderson; W E Mercer; E Appella
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

5.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently.

Authors:  P M O'Connor; D K Ferris; M Pagano; G Draetta; J Pines; T Hunter; D L Longo; K W Kohn
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

Review 7.  Cell cycle regulation and the p53 tumor suppressor protein.

Authors:  W E Mercer
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1992       Impact factor: 1.807

8.  Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.

Authors:  E Lees; B Faha; V Dulic; S I Reed; E Harlow
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

9.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

10.  Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.

Authors:  M Fiscella; S J Ullrich; N Zambrano; M T Shields; D Lin; S P Lees-Miller; C W Anderson; W E Mercer; E Appella
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

View more
  26 in total

1.  The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT.

Authors:  Xiaolin Li; Donald P McDonnell
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Activation of human B-MYB by cyclins.

Authors:  A Sala; M Kundu; I Casella; A Engelhard; B Calabretta; L Grasso; M G Paggi; A Giordano; R J Watson; K Khalili; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene.

Authors:  Xueli Fan; Jason J Chen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

4.  Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365.

Authors:  Michael Papetti; Leonard H Augenlicht
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-07       Impact factor: 4.052

5.  Downregulation of B-myb promotes senescence via the ROS-mediated p53/p21 pathway, in vascular endothelial cells.

Authors:  Zhihui Zhou; Yanlin Yin; Qun Chang; Guanqun Sun; Jiahui Lin; Yalei Dai
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

6.  Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage.

Authors:  U M Moll; A G Ostermeyer; R Haladay; B Winkfield; M Frazier; G Zambetti
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Mutation of the Drosophila homologue of the Myb protooncogene causes genomic instability.

Authors:  J Robert Manak; Nesanet Mitiku; Joseph S Lipsick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

8.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.

Authors:  J DeGregori; T Kowalik; J R Nevins
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 9.  B-Myb, cancer, senescence, and microRNAs.

Authors:  Ivan Martinez; Daniel Dimaio
Journal:  Cancer Res       Date:  2011-08-09       Impact factor: 12.701

10.  Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.

Authors:  B Rudolph; R Saffrich; J Zwicker; B Henglein; R Müller; W Ansorge; M Eilers
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.